Breaking Down Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd Financial Health: Key Insights for Investors

Peel back the numbers on Chengdu Information Technology of Chinese Academy of Sciences Co., Ltd (300678.SZ) and investors face a mixed picture: quarterly revenue slid to 52.20 million CNY (down 21.71% YoY) with TTM revenue at 482.52 million CNY (down 21.36% YoY) and 2024 sales of 507.00 million CNY, while profitability is strained-TTM net income just 7.90 million CNY for a slim 1.68% profit margin amid a negative operating margin of -5.43% and EPS of 0.03 CNY-yet the balance sheet shows resilience with a net cash position of 349.58 million CNY, total cash of 476.1 million CNY, negligible debt (debt/equity 0.01), strong liquidity ratios (current 3.21, quick 2.17) and an Altman Z-Score of 20.98; valuation contrasts this stability with a steep market pricing-market cap near 9.17 billion CNY and a trailing P/E of 1,164.37 and P/S of 19.01-while growth avenues in AI, anesthesia and infrastructure robotics, plus ties to the Chinese Academy of Sciences, sit against risks from delayed tenders, policy dependence and competitive pressure, so read on to dissect cash flow (TTM operating cash flow 63.59 million CNY, free cash flow 62.58 million CNY), low capex (1.0 million CNY), book value per share 2.85 CNY, ROE 0.67% and a Piotroski F-Score of 3 to determine whether the company's defensive low beta (0.076) and strong cash cushion justify the current premium valuation or signal caution

Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) Revenue Analysis

The company reported a clear downward trend in top-line performance driven by delayed customer tenders and a slowdown in industry demand. Recent reported figures highlight both quarterly deterioration and a marked year-over-year decline across the trailing twelve months and full-year 2024 results.

• Quarter ended Sep 30, 2025: Revenue 52.20 million CNY (-21.71% YoY).
• Trailing twelve months (TTM) revenue: 482.52 million CNY (-21.36% YoY).
• Full-year 2024 revenue: 507.00 million CNY (-14.27% vs 591.40 million CNY in 2023).
• Revenue per employee: ~756,290 CNY (638 employees).
• Market capitalization (Nov 20, 2025): 9.17 billion CNY; P/S ratio: 19.01.

Key implications for investors center on revenue volatility from timing of tenders and sector demand shifts: near-term visibility is lowered while the high P/S multiple (19.01) implies market expectations of future growth or profitability improvement despite current declines.

• Primary drivers of revenue decline: delayed customer tenders, slower industry demand.
• Operational productivity: revenue per employee ~756,290 CNY suggests moderate per-capita output versus peers (investors should benchmark to comparable firms).
• Valuation context: market cap 9.17 billion CNY with P/S 19.01-sensitivity to revenue recovery is high.

For fuller investor context and shareholder composition, see: Exploring Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd Investor Profile: Who's Buying and Why?

Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) - Profitability Metrics

Key profitability figures for Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) show a company operating with very thin margins and limited returns to shareholders over the recent period.

• Very low net income (7.90M CNY TTM) produces a slim profit margin (1.68%), indicating limited pricing power or narrow margins in core activities.
• Sharp decline in 2024 net profit (9.58M CNY, -75.10% YoY) signals one-off losses, margin compression, or weaker demand compared with the prior year.
• Negative operating margin (-5.43%) highlights operational inefficiencies or higher operating costs relative to revenue, which precedes net profitability pressure.
• ROE of 0.67% shows minimal return for shareholders; equity base is yielding very little profit generation.
• Tiny EPS (0.03 CNY) combined with an extreme P/E (1,119.57) suggests market price may not reflect underlying earnings stability - P/E likely inflated by low EPS or volatile earnings.
• Dividend policy is modest (0.05 CNY, 0.15% yield), offering negligible income return to investors and limited signal of strong free cash flow.

For context on corporate direction and longer-term aims, see the company's mission and vision documentation: Mission Statement, Vision, & Core Values (2026) of Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd.

Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) - Debt vs. Equity Structure

• Debt-to-equity ratio: 0.01 - extremely low leverage.
• Net cash position: 349.58 million CNY.
• Total cash & equivalents: 476.10 million CNY versus total debt: 18.40 million CNY.
• Current ratio: 3.21 - ample short-term liquidity.
• Quick ratio: 2.17 - sufficient immediate liquidity excluding inventories.
• Equity (book value): 848.34 million CNY; book value per share: 2.85 CNY.

• Liquidity profile supports working capital and potential opportunistic investments.
• Low leverage reduces interest expense volatility and financial distress risk.
• Book value of 848.34 million CNY provides a tangible equity cushion.

Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) - Liquidity and Solvency

Key liquidity and solvency indicators for Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) show solid cash generation and very low market sensitivity, but mixed signals from accounting-quality metrics.

• Trailing twelve months operating cash flow: 63.59 million CNY - a positive indicator of core cash generation capacity.
• Capital expenditures (CAPEX): 1.0 million CNY - minimal investment outlay consistent with an asset-light model.
• Free cash flow (FCF): 62.58 million CNY - strong FCF providing flexibility for dividends, buybacks, deleveraging, or strategic investments.
• Beta: 0.076 - extremely low correlation with broader market movements, implying limited market-driven volatility for the equity.
• Altman Z-Score: 20.98 - a very high score indicating a low likelihood of bankruptcy under the Altman model.
• Piotroski F-Score: 3 - a low score that signals potential concerns over accounting quality, profitability trends, or financial strength metrics.

Implications for investors:

• Strong operating cash flow and near-equal FCF imply internal funding is sufficient for short-term needs and selective strategic moves.
• Minimal CAPEX suggests scalability without heavy fixed-asset commitments, but could also indicate limited growth-driven reinvestment.
• Extremely low beta can make the stock attractive for risk-averse portfolios seeking idiosyncratic exposure within the sector.
• The Altman Z-Score reduces immediate insolvency concerns, but a Piotroski F-Score of 3 warrants deeper due diligence into earnings quality, accruals, and balance-sheet changes.

For additional context on corporate background, ownership and how the company operates, see: Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) - Valuation Analysis

Key valuation metrics paint a picture of a stock trading at a substantial premium across earnings, book value and revenue, with limited observable profitability measures.

• Trailing P/E: 1,164.37 - extreme valuation relative to current trailing earnings, implying very low or volatile EPS.
• P/B: 11.47 - market price ~11.5x reported book value, indicating investor willingness to pay for intangible assets or future growth expectations.
• P/S: 19.58 - high multiple on sales, signaling lofty revenue-based valuation.
• EV/Revenue: 18.88 - enterprise value implies a premium relative to revenues, consistent with P/S.
• EV/EBITDA: not available - suggests negative, negligible or non-disclosable EBITDA, limiting standard operating-profit valuation comparisons.
• Market capitalization: 9.73 billion CNY as of 2025-10-21, up 53.48% over the past year - strong market-cap appreciation despite stretched multiples.

Valuation context and investor signals:

• High multiples across P/E, P/B and P/S typically reflect expectations of significant future growth, strong intangible assets (IP, R&D) or scarcity of comparable peers.
• Absence of EV/EBITDA implies limited current operating profitability - investors appear to price forward potential rather than present cash returns.
• Rapid market-cap appreciation (+53.48% Y/Y) suggests active investor interest; however, elevated multiples increase sensitivity to any earnings or revenue setbacks.

For background on the company's history, ownership and business model, see: Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) - Risk Factors

• Dependence on government spending: a significant portion of contracts are tied to municipal, provincial or national public-sector projects, making revenues sensitive to shifts in budget priorities and procurement timing.
• Intense industry competition: domestic and international software service providers and system integrators compete on price, technology and delivery speed, exerting margin pressure.
• Demand cyclicality and procurement timing: historically, the company has experienced revenue volatility when large customer tenders are delayed or when end-market demand softens.
• R&D investment pressure: management has increased R&D spending to capture higher-value contracts and product differentiation, which can compress short-term profitability.
• Regulatory and policy risk: changes in data security, procurement rules, preferential financing or industry-specific regulations could materially alter business economics.
• Low market sensitivity (beta): the company's low historical beta implies limited correlation with broader market moves, which may reduce upside participation in bull markets and limit volatility-based trading opportunities.

• Impact scenarios: a 10-20% cut in government project budgets in key regions could reduce near-term revenue growth materially; a sustained 3-5 percentage-point increase in R&D spend without corresponding contract wins could lower net margin by several hundred basis points.
• Operational sensitivities: reliance on public tenders means quarter-to-quarter revenue timing risk - a single large tender delay can shift 5-15% of expected quarterly revenue into later periods.
• Competitive pricing pressure: if competitors win share by lowering prices, expect margin contraction unless offset by higher-value product mix or efficiency gains.

• Management levers and mitigants:
  • Diversify client mix toward stable recurring contracts and non-government end markets;
  • Focus R&D on commercializable platform modules to shorten payback and improve gross margins;
  • Improve working-capital management to smooth tender-driven cashflow variability;
  • Hedge regulatory exposure via compliance investments and proactive policy engagement.

Chengdu Information Technology of Chinese Academy of Sciences Co.,Ltd (300678.SZ) - Growth Opportunities

• New market expansion: clinical anesthesia devices and infrastructure robotics are targeted to broaden the addressable market beyond the company's legacy imaging and sensing products.
• AI-driven product innovation: embedding machine learning and computer vision into diagnostic equipment and robotic platforms can raise product differentiation and command premium margins.
• Institutional credibility: affiliation with the Chinese Academy of Sciences supports access to government procurement channels, collaborative R&D grants and technology transfer opportunities.
• Sector diversification: exposure across healthcare equipment, industrial automation and AI software mitigates single-sector cyclicality and opens multiple revenue streams.
• Balance-sheet optionality: a conservative cash position allows for bolt-on M&A, strategic partnerships and accelerated commercialization of new product lines.
• Defensive investor appeal: a historically low beta implies lower sensitivity to market swings, attractive to risk-averse shareholders seeking steady capital preservation with upside from new initiatives.

• Market catalysts to monitor:
  • Regulatory approvals for anesthesia devices and clinical adoption rates.
  • Commercial pilots and procurement awards for infrastructure robotics in smart city projects.
  • AI-embedded product releases and evidence of improved clinical/operational outcomes.
  • Strategic partnerships leveraging the Chinese Academy of Sciences network for government contracts.